Natco Pharma Ltd.

BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
927.15
3.50 (0.38%)
< Home < Back

NATCO Pharma informs about certificate

Date: 08-04-2022

NATCO Pharma has informed that it enclosed Certificate under Regulation 74{5) of the SEBI (Depositories and Participants) Regulations for the quarter ended March 31, 2022.

The above information is a part of company’s filings submitted to BSE.